N🟁N

Celera to Webcast Its Presentation at the Piper Jaffray Healthcare Conference

  //science-technology.news-articles.net/content/2 .. -at-the-piper-jaffray-healthcare-conference.html
  Published in Science and Technology on Tuesday, November 25th 2008 at 6:00 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

ALAMEDA, Calif.--([ BUSINESS WIRE ])--Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the 20^TH Annual Piper Jaffray Healthcare conference on Tuesday, December 2, 2008. The live webcast is scheduled to begin at 1:30 p.m. ET when Kathy Ordoñez, Chief Executive Officer of Celera, will provide a brief overview of Celera's business, followed by a question and answer session with investors and a Piper Jaffray financial analyst.

Interested parties may access the live webcast and replay by visiting the Investors & Media section of the Celera website at [ www.celera.com ]. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Investors & Media section of website.

About Celera

Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at [ http://www.celera.com ].

Copyright© 2008. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.